Genpact Limited Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Genpact Limited payments for repurchase of common stock for the quarter ending 2021-12-31 was $151.07M, a 137.68% increase year-over-year.
- Genpact Limited payments for repurchase of common stock for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Genpact Limited payments for repurchase of common stock for the quarter ending 2021-06-30 was $12.93M.
- Genpact Limited payments for repurchase of common stock for the quarter ending 2021-03-31 was $134.22M, a 198.12% increase year-over-year.
- Genpact Limited payments for repurchase of common stock for fiscal 2024 was $252.67M, a 12.05% increase from fiscal 2023.
- Genpact Limited payments for repurchase of common stock for fiscal 2023 was $225.50M, a 5.33% increase from fiscal 2022.
- Genpact Limited payments for repurchase of common stock for fiscal 2022 was $214.08M, a 28.21% decline from fiscal 2021.
- Genpact Limited payments for repurchase of common stock for fiscal 2021 was $298.22M, a 117.50% increase from fiscal 2020.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $252.67M 10-K · filed 2025-03-03 | |
| 2023-12-31 | $225.50M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $214.08M 10-K · filed 2025-03-03 | |
| 2021-12-31 | $151.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $298.22M 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $210.71M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $12.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $239.26M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $134.22M 10-Q · filed 2021-05-10 | $226.31M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $63.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $137.11M 10-K · filed 2023-03-01 |
| 2020-09-30 | $28.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $79.65M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | |
| 2020-03-31 | $45.02M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $30.02M 10-K · filed 2022-03-01 |
| 2018-12-31 | $24.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $154.16M 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $130.10M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $34.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $130.10M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $95.98M 10-Q · filed 2019-05-10 | $95.98M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $219.78M 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $322.43M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 8-K 3 month · filed 2018-08-09 | $478.58M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $219.78M 8-K · filed 2018-06-04 | $531.97M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $102.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $345.20M 10-K · filed 2019-03-01 |
| 2016-09-30 | $156.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $310.43M derived: sum of 4 quarters · filed 2018-06-04 |
| 2016-06-30 | $53.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $231.92M derived: sum of 4 quarters · filed 2018-06-04 |
| 2016-03-31 | $33.02M 10-Q · filed 2017-05-10 | $246.63M derived: sum of 4 quarters · filed 2018-06-04 |
| 2015-12-31 | $67.88M derived: 8-K 12 month − 10-Q 9 month · filed 2018-06-04 | $226.92M 8-K · filed 2018-06-04 |
| 2015-09-30 | $77.64M 10-Q · filed 2015-11-06 | $159.03M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $68.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $81.40M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $13.30M 10-Q · filed 2016-05-09 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $302.63M 10-K · filed 2017-03-01 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |